Dose-escalating study of the safety and pharmacokinetics of nelfinavir in HIV-exposed neonates.
Rongkavilit C, van Heeswijk RP, Limpongsanurak S, Thaithumyanon P, Boonrod C, Hassink EA, Srigritsanapol A, Chuenyam T, Ubolyam S, Hoetelmans RM, Ruxrungtham K, Lange JM, Cooper DA, Phanuphak P.
Rongkavilit C, et al. Among authors: ruxrungtham k.
J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):455-63. doi: 10.1097/00042560-200204150-00005.
J Acquir Immune Defic Syndr. 2002.
PMID: 11981361
Clinical Trial.